Literature DB >> 6833297

Rabbit myocardial cytosolic lysophospholipase. Purification, characterization, and competitive inhibition by L-palmitoyl carnitine.

R W Gross, B E Sobel.   

Abstract

Rabbit myocardial lysophospholipase was purified 27,000-fold to near homogeneity by ammonium sulfate precipitation, DEAE-Sephacel, gel filtration, chromatofocusing, and hydroxylapatite chromatography. Chromatofocusing demonstrated two activity peaks, each with a molecular mass of 23,000 daltons by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Both activity peaks had similar kinetic parameters (Vmax = 7 mumols/mg/min, Km = 9-11 microM) and similar pH profiles (7.5 optimum). Each activity peak was competitively inhibited by L-palmitoylcarnitine with similar inhibitory constants (KI = 10-11 microM). In addition, palmitic acid competitively inhibited myocardial lysophospholipase (KI = 37 microM). A rapid loss of lysophospholipase activity resulted from heating at 37 degrees C in the absence of substrate (t1/2 = 3 min). This thermal denaturation was attenuated similarly by either lysophosphatidylcholine (15 microM) or L-palmitoylcarnitine (15 microM). Thus, L-palmitoylcarnitine complexes with purified myocardial lysophospholipase and competitively inhibits a major pathway of lysophosphatidylcholine catabolism, thereby potentially contributing to accumulation of lysophosphatides in ischemic myocardium and ventricular dysrhythmia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833297

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium.

Authors:  K A Yamada; D J Dobmeyer; E M Kanter; S G Priori; P B Corr
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Molecular characterization and serodiagnosis analysis of a novel lysophospholipase from Clonorchis sinensis.

Authors:  Changling Ma; Xuchu Hu; Fengyu Hu; Yanwen Li; Xiaoxiang Chen; Zhenwen Zhou; Fangli Lu; Jin Xu; Zhongdao Wu; Xinbing Yu
Journal:  Parasitol Res       Date:  2007-02-23       Impact factor: 2.289

3.  Mechanism of lysophosphatidylcholine accumulation in the ischemic canine heart.

Authors:  T Mock; R Y Man
Journal:  Lipids       Date:  1990-07       Impact factor: 1.880

Review 4.  Subcellular distribution, molecular dynamics and catabolism of plasmalogens in myocardium.

Authors:  L A Scherrer; R W Gross
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

5.  Interaction of palmitoyl carnitine with calcium antagonists in myocytes.

Authors:  L Patmore; G P Duncan; M Spedding
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

6.  Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism.

Authors:  Christopher M Jenkins; Jingyue Yang; Harold F Sims; Richard W Gross
Journal:  J Biol Chem       Date:  2011-01-23       Impact factor: 5.157

7.  Lysophospholipases cooperate to mediate lipid homeostasis and lysophospholipid signaling.

Authors:  James A Wepy; James J Galligan; Philip J Kingsley; Shu Xu; Michael C Goodman; Keri A Tallman; Carol A Rouzer; Lawrence J Marnett
Journal:  J Lipid Res       Date:  2018-11-27       Impact factor: 5.922

8.  Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.

Authors:  P B Corr; M H Creer; K A Yamada; J E Saffitz; B E Sobel
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  The substrate specificities of four different lysophospholipases as determined by a novel fluorescence assay.

Authors:  H S She; D E Garsetti; M R Steiner; R W Egan; M A Clark
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

10.  Lysophospholipase activity in rat brain subcellular fractions.

Authors:  G Y Sun; W Tang; S F Huang; R MacQuarrie
Journal:  Neurochem Res       Date:  1987-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.